InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,730.86
(
0.21%
)
US TECH 100
19,370.40
(
0.25%
)
Dow Jones
42,171.19
(
0.11%
)
Brent Oil
74.48
(
1.00%
)
Bitcoin
63,211.80
(
-0.18%
)
Post# of 10809
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Bobwins

Send PM Follow Ignore
Followers 556
Posts 17440
Boards Moderated 42
Alias Born 10/21/2003

Bobwins

Re: Bobwins post# 10612

Thursday, 08/29/2019 2:41:05 PM

Thursday, August 29, 2019 2:41:05 PM

Post# of 10809
ATE.v/ATBPF +.05 to C$.39

After a huge drop due to delay in phase II trial enrollments that will delay final results by a couple of months, Zack's published a report that reminded market how close we are to a final phase II study AND huge potential of ATB-346 to become a billion dollar drug.

https://scr.zacks.com/News/Press-Releases/Press-Release-Details/2019/VATE-Phase-2b-Efficacy-Data-Expected-in-4Q19-article/default.aspx

Please post stock symbols first in all your posts. If it's a foreign stock, please list the US pk equivalent symbol.

If the Commodities Boom is Over, I am just a Gold Bug headed for the Windshield of LIFE

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up